Risk factors for inflammatory bowel disease in the general population

被引:140
作者
Rodríguez, LAG
González-Pérez, A
Johansson, S
Wallander, MA
机构
[1] Ctr Espanol Invest Farmacoepidemiol, Madrid, Spain
[2] AstraZeneca R&D, Molndal, Sweden
[3] Gothenburg Univ, Sect Prevent Cardiol, S-41124 Gothenburg, Sweden
[4] Univ Uppsala, Dept Publ Hlth & Caring Sci, S-75105 Uppsala, Sweden
关键词
D O I
10.1111/j.1365-2036.2005.02564.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: The aetiology of inflammatory bowel disease remains largely unknown. Aim: We performed a comprehensive assessment of potential risk factors associated with the occurrence of inflammatory bowel disease. Methods:We identified a cohort of patients 20-84 years old between 1995 and 1997 registered in the General Practitioner Research Database in the UK. A total of 444 incident cases of IBD were ascertained and validated with the general practitioner. We performed a nested case-control analysis using all cases and a random sample of 10 000 frequency-matched controls. Results: Incidence rates for ulcerative colitis, Crohn's disease, and indeterminate colitis were 11, 8, and 2 cases per 100 000 person-years, respectively. Among women, we found that long-term users of oral contraceptives were at increased risk of developing UC (OR: 2.35; 95% CI: 0.89-6.22) and CD (OR: 3.15; 95% CI: 1.24-7.99). Similarly, long-term users of HRT had an increased risk of CD (OR: 2.60; 95% CI: 1.04-6.49) but not UC. Current smokers experienced a reduced risk of UC along with an increased risk of CD. Prior appendectomy was associated with a decreased the risk of UC (OR: 0.37; 95% CI: 0.14-1.00). Conclusions: Our results support the hypothesis of an increased risk of inflammatory bowel disease associated with oral contraceptives use and suggest a similar effect of hormone replacement therapy on CD. We also confirmed the effects of smoking and appendectomy on inflammatory bowel disease.
引用
收藏
页码:309 / 315
页数:7
相关论文
共 14 条
[1]
Inflammatory bowel disease: A study of the association between anxiety and depression, physical morbidity, and nutritional status [J].
Addolorato, G ;
Capristo, E ;
Stefanini, GF ;
Gasbarrini, G .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1997, 32 (10) :1013-1021
[2]
Appendectomy protects against ulcerative colitis [J].
Derby, LE ;
Jick, H .
EPIDEMIOLOGY, 1998, 9 (02) :205-207
[3]
Systematic review: is ingestion of paracetamol or non-steroidal anti-inflammatory drugs associated with exacerbations of inflammatory bowel disease? [J].
Forrest, K ;
Symmons, D ;
Foster, P .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2004, 20 (10) :1035-1043
[4]
VALIDATION OF INFORMATION RECORDED ON GENERAL-PRACTITIONER BASED COMPUTERIZED DATA RESOURCE IN THE UNITED-KINGDOM [J].
JICK, H ;
JICK, SS ;
DERBY, LE .
BRITISH MEDICAL JOURNAL, 1991, 302 (6779) :766-768
[5]
KENNY SJ, 1995, NIH PUBLICATION, P47
[6]
Role of appendicitis and appendectomy in the pathogenesis of ulcerative colitis: A critical review [J].
Koutroubakis, IE ;
Vlachonikolis, IG ;
Kouroumalis, EA .
INFLAMMATORY BOWEL DISEASES, 2002, 8 (04) :277-286
[7]
Depression and anxiety in people with inflammatory bowel disease [J].
Kurina, LM ;
Goldacre, MJ ;
Yeates, D ;
Gill, LE .
JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 2001, 55 (10) :716-720
[8]
Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences [J].
Loftus, EV .
GASTROENTEROLOGY, 2004, 126 (06) :1504-1517
[9]
TIME RELATIONSHIPS BETWEEN CESSATION OF SMOKING AND ONSET OF ULCERATIVE-COLITIS [J].
MOTLEY, RJ ;
RHODES, J ;
FORD, GA ;
WILKINSON, SP ;
CHESNER, IM ;
ASQUITH, P ;
HELLIER, MD ;
MAYBERRY, JF .
DIGESTION, 1987, 37 (02) :125-127
[10]
Reif S, 2000, AM J GASTROENTEROL, V95, P474